These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22751730)

  • 1. Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II.
    Alquicer G; Sedlák D; Byun Y; Pavlícek J; Stathis M; Rojas C; Slusher B; Pomper MG; Bartunek P; Barinka C
    J Biomol Screen; 2012 Sep; 17(8):1030-40. PubMed ID: 22751730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of fluorescence polarization detection for the measurement of fluopeptidetm binding to G protein-coupled receptors.
    Gagne A; Banks P; Hurt SD
    J Recept Signal Transduct Res; 2002; 22(1-4):333-43. PubMed ID: 12503625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.
    Tykvart J; Schimer J; Bařinková J; Pachl P; Poštová-Slavětínská L; Majer P; Konvalinka J; Šácha P
    Bioorg Med Chem; 2014 Aug; 22(15):4099-108. PubMed ID: 24954515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
    Chen Y; Fu Z; Li D; Yue Y; Liu X
    Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.
    Neburkova J; Sedlak F; Zackova Suchanova J; Kostka L; Sacha P; Subr V; Etrych T; Simon P; Barinkova J; Krystufek R; Spanielova H; Forstova J; Konvalinka J; Cigler P
    Mol Pharm; 2018 Aug; 15(8):2932-2945. PubMed ID: 29389139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Fluorescence Polarization in HTS Assays.
    Huang X; Aulabaugh A
    Methods Mol Biol; 2016; 1439():115-30. PubMed ID: 27316991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.
    Plechanovová A; Byun Y; Alquicer G; Skultétyová L; Mlčochová P; Němcová A; Kim HJ; Navrátil M; Mease R; Lubkowski J; Pomper M; Konvalinka J; Rulíšek L; Bařinka C
    J Med Chem; 2011 Nov; 54(21):7535-46. PubMed ID: 21923190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationally designed sulfamides as glutamate carboxypeptidase II inhibitors.
    Choy CJ; Fulton MD; Davis AL; Hopkins M; Choi JK; Anderson MO; Berkman CE
    Chem Biol Drug Des; 2013 Nov; 82(5):612-9. PubMed ID: 23773397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate carboxypeptidase II does not process amyloid-β peptide.
    Sedlák F; Šácha P; Blechová M; Březinová A; Šafařík M; Šebestík J; Konvalinka J
    FASEB J; 2013 Jul; 27(7):2626-32. PubMed ID: 23525279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.
    Du Y; Nikolovska-Coleska Z; Qui M; Li L; Lewis I; Dingledine R; Stuckey JA; Krajewski K; Roller PP; Wang S; Fu H
    Assay Drug Dev Technol; 2011 Aug; 9(4):382-93. PubMed ID: 21395401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.
    Barinka C; Sácha P; Sklenár J; Man P; Bezouska K; Slusher BS; Konvalinka J
    Protein Sci; 2004 Jun; 13(6):1627-35. PubMed ID: 15152093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.
    Ferraris DV; Shukla K; Tsukamoto T
    Curr Med Chem; 2012; 19(9):1282-94. PubMed ID: 22304717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.
    Mlcochová P; Plechanovová A; Barinka C; Mahadevan D; Saldanha JW; Rulísek L; Konvalinka J
    FEBS J; 2007 Sep; 274(18):4731-41. PubMed ID: 17714508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a novel BODIPY-labeled PSMA inhibitor.
    Son SH; Kwon H; Ahn HH; Nam H; Kim K; Nam S; Choi D; Ha H; Minn I; Byun Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126894. PubMed ID: 31874825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput fluorescence polarization method for identifying ligands of LOX-1.
    Zhang TT; Huang ZT; Dai Y; Chen XP; Zhu P; Du GH
    Acta Pharmacol Sin; 2006 Apr; 27(4):447-52. PubMed ID: 16539845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1.
    Thompson S; Messick T; Schultz DC; Reichman M; Lieberman PM
    J Biomol Screen; 2010 Oct; 15(9):1107-15. PubMed ID: 20930215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of
    Temml V; Kollár J; Schönleitner T; Höll A; Schuster D; Kutil Z
    J Chem Inf Model; 2023 Feb; 63(4):1249-1259. PubMed ID: 36799916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay.
    Cho EJ; Xia S; Ma LC; Robertus J; Krug RM; Anslyn EV; Montelione GT; Ellington AD
    J Biomol Screen; 2012 Apr; 17(4):448-59. PubMed ID: 22223052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.
    Wang Z; Bhattacharya A; Ivanov DN
    PLoS One; 2015; 10(9):e0138780. PubMed ID: 26390015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.